Literature DB >> 9343206

Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity.

C Yang1, R W Compans.   

Abstract

In previous studies, the C-terminal R peptide of the murine leukemia virus (MuLV) Env protein was shown to be a potent inhibitor of viral fusion activity. In the present study, we investigated the molecular determinants in the MuLV Env protein cytoplasmic tail which are important for the fusion inhibition activity of the R peptide. We constructed a series of mutant MuLV env genes which express Env proteins with serial truncations, internal deletions, or amino acid substitutions in the cytoplasmic tail. To analyze their cell fusion activity, we employed a quantitative fusion assay. We found that truncations of up to 7 amino acids from the C terminus of the cytoplasmic tail had no detectable effect on the lack of fusion activity of the full-length Env protein; however, further truncations resulted in a progressive increase in cell fusion activity. Studies of mutant proteins with amino acid substitutions in the cytoplasmic tail showed that Leu-627 plays an important role in fusion inhibition by the R peptide, while most of the other amino acids in the R peptide were not essential for fusion inhibition. Studies of mutant proteins with internal deletions upstream of the cleavage site in the cytoplasmic tail showed that this region is also involved in fusion inhibition by the R peptide, although only to a limited extent. The results are consistent with a model in which the MuLV R peptide exhibits its fusion inhibition activity through interaction with a cellular factor(s).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343206      PMCID: PMC192312     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses.

Authors:  J L Battini; J M Heard; O Danos
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses.

Authors:  P L Earl; S Koenig; B Moss
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 3.  Viral and cellular membrane fusion proteins.

Authors:  J M White
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

4.  Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.

Authors:  M J Mulligan; G V Yamshchikov; G D Ritter; F Gao; M J Jin; C D Nail; C P Spies; B H Hahn; R W Compans
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity.

Authors:  L Chakrabarti; M Emerman; P Tiollais; P Sonigo
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  HIV-induced syncytium formation requires the formation of conjugates between virus-infected and uninfected T-cells in vitro.

Authors:  M Busso; J Thornthwaite; L Resnick
Journal:  AIDS       Date:  1991-12       Impact factor: 4.177

7.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

8.  Re-evaluation of the involvement of the adhesion molecules ICAM-1/LFA-1 in syncytia formation of HIV-1-infected subclones of a CEM T-cell leukemic line.

Authors:  M F Gruber; D S Webb; T L Gerrard; H S Mostowski; L Vujcic; H Golding
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

9.  Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage.

Authors:  M A Sommerfelt; S R Petteway; G B Dreyer; E Hunter
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  34 in total

1.  Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.

Authors:  John T West; Sally K Weldon; Stephanie Wyss; Xiaoxu Lin; Qin Yu; Markus Thali; Eric Hunter
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells.

Authors:  U Krach; N Fischer; F Czauderna; R R Tönjes
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Identification of two intracellular mechanisms leading to reduced expression of oncoretrovirus envelope glycoproteins at the cell surface.

Authors:  M P Grange; V Blot; L Delamarre; I Bouchaert; A Rocca; A Dautry-Varsat; M C Dokhélar
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.

Authors:  Shaguna Seth; Annelet Vincent; R W Compans
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

5.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Mutations in multiple domains activate paramyxovirus F protein-induced fusion.

Authors:  Shaguna Seth; Andrew L Goodman; Richard W Compans
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Maturation cleavage of the murine leukemia virus Env precursor separates the transmembrane subunits to prime it for receptor triggering.

Authors:  Robin Löving; Shang-Rung Wu; Mathilda Sjöberg; Birgitta Lindqvist; Henrik Garoff
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

8.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles.

Authors:  Christoph A Merten; Jörn Stitz; Gundula Braun; Eric M Poeschla; Klaus Cichutek; Christian J Buchholz
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

10.  Retrovirus glycoprotein functionality requires proper alignment of the ectodomain and the membrane-proximal cytoplasmic tail.

Authors:  Sanath Kumar Janaka; Devon A Gregory; Marc C Johnson
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.